These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy. Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C Front Immunol; 2018; 9():2247. PubMed ID: 30323818 [No Abstract] [Full Text] [Related]
3. Comparison of the frequency and phenotypic profile of Du Bruyn E; Ruzive S; Howlett P; Jacobs AJ; Arlehamn CSL; Sette A; Sher A; Mayer-Barber KD; Barber DL; Mayosi B; Ntsekhe M; Wilkinson RJ; Riou C Front Immunol; 2022; 13():1009016. PubMed ID: 36439130 [TBL] [Abstract][Full Text] [Related]
4. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response. Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019 [TBL] [Abstract][Full Text] [Related]
5. Activation Phenotype of Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z Front Immunol; 2021; 12():721013. PubMed ID: 34512645 [TBL] [Abstract][Full Text] [Related]
6. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment. Díaz-Fernández S; Villar-Hernández R; Stojanovic Z; Fernández M; Galvão MLS; Tolosa G; Sánchez-Montalva A; Abad J; Jiménez-Fuentes MÁ; Safont G; Romero I; Sabrià J; Prat C; Domínguez J; Latorre I Front Microbiol; 2022; 13():885312. PubMed ID: 35935194 [TBL] [Abstract][Full Text] [Related]
7. Tuberculosis Treatment Response Monitoring by the Phenotypic Characterization of Sitoe N; Ahmed MIM; Enosse M; Bakuli A; Chissumba RM; Held K; Hoelscher M; Nhassengo P; Khosa C; Rachow A; Geldmacher C; On Behalf Of Tb Sequel Consortium Pathogens; 2022 Sep; 11(9):. PubMed ID: 36145465 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the Phenotype of Riou C; Berkowitz N; Goliath R; Burgers WA; Wilkinson RJ Front Immunol; 2017; 8():968. PubMed ID: 28848561 [TBL] [Abstract][Full Text] [Related]
9. High Frequencies of Caspase-3 Expressing Adekambi T; Ibegbu CC; Cagle S; Ray SM; Rengarajan J Front Immunol; 2018; 9():1481. PubMed ID: 29983703 [TBL] [Abstract][Full Text] [Related]
10. Impact of antiretroviral and tuberculosis therapies on CD4 Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002 [TBL] [Abstract][Full Text] [Related]
12. Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection. Chiacchio T; Delogu G; Vanini V; Cuzzi G; De Maio F; Pinnetti C; Sampaolesi A; Antinori A; Goletti D PLoS One; 2017; 12(8):e0183846. PubMed ID: 28837654 [TBL] [Abstract][Full Text] [Related]
13. CD4 T Cells in McLaughlin TA; Khayumbi J; Ongalo J; Tonui J; Campbell A; Allana S; Gurrion Ouma S; Odhiambo FH; Gandhi NR; Day CL Front Immunol; 2020; 11():127. PubMed ID: 32117277 [No Abstract] [Full Text] [Related]
15. Study of CD27 and CCR4 Markers on Specific CD4 Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J Front Immunol; 2018; 9():3094. PubMed ID: 30687314 [TBL] [Abstract][Full Text] [Related]
16. Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis. Prezzemolo T; Guggino G; La Manna MP; Di Liberto D; Dieli F; Caccamo N Front Immunol; 2014; 5():180. PubMed ID: 24795723 [TBL] [Abstract][Full Text] [Related]
17. CD38+CD27-TNF-α + on Mtb-specific CD4+ T Cells Is a Robust Biomarker for Tuberculosis Diagnosis. Acharya MP; Pradeep SP; Murthy VS; Chikkannaiah P; Kambar V; Narayanashetty S; Burugina Nagaraja S; Gangadhar N; Yoganand R; Satchidanandam V Clin Infect Dis; 2021 Sep; 73(5):793-801. PubMed ID: 34492697 [TBL] [Abstract][Full Text] [Related]
18. Mtb-specific CD27low CD4 T cells as markers of lung tissue destruction during pulmonary tuberculosis in humans. Nikitina IY; Kondratuk NA; Kosmiadi GA; Amansahedov RB; Vasilyeva IA; Ganusov VV; Lyadova IV PLoS One; 2012; 7(8):e43733. PubMed ID: 22937086 [TBL] [Abstract][Full Text] [Related]
19. Combination of HLA-DR on Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z Front Immunol; 2021; 12():761209. PubMed ID: 34858413 [TBL] [Abstract][Full Text] [Related]
20. PD-1 Expression and Cytokine Secretion Profiles of Mycobacterium tuberculosis-Specific CD4+ T-Cell Subsets; Potential Correlates of Containment in HIV-TB Co-Infection. Pollock KM; Montamat-Sicotte DJ; Grass L; Cooke GS; Kapembwa MS; Kon OM; Sampson RD; Taylor GP; Lalvani A PLoS One; 2016; 11(1):e0146905. PubMed ID: 26756579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]